Stock Events

Stock Events

Sera Prognostics 

$2.05
14
-$0.15-6.82% Friday 20:00
+$0.00+0%Friday 20:00After hours

Statistics

Day High
2.05
Day Low
2.04
52W High
3.95
52W Low
1.56
Volume
1,523
Avg. Volume
-
Mkt Cap
80.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12AugExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.25
-0.22
-0.19
-0.15
Expected EPS
-0.154225
Actual EPS
N/A

Financials

-39,417.28%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
81,000Revenue
-31.93MNet Income

Analyst Ratings

6.00Average Price Target
The highest estimate is 6.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SERA. It's not an investment recommendation.
NVIDIA
4
NVDA
AMD
4
AMD
BERKSHIRE HATHAWAY
4
BRK.B
Super Micro Computer
4
SMCI

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Natera
NTRA
Mkt Cap38.66B
Natera offers prenatal screening tests, directly competing with Sera Prognostics' offerings in the maternal and fetal health space.
Illumina
ILMN
Mkt Cap28.78B
Illumina provides genomic sequencing solutions that are foundational to developing prenatal tests, making them a key competitor in the broader market for genetic testing related to pregnancy.
Quest Diagnostics
DGX
Mkt Cap22.96B
Quest Diagnostics offers a range of maternal and fetal health tests, including genetic testing, competing with Sera Prognostics in the clinical lab testing market.
Labcorp
LH
Mkt Cap22.7B
LabCorp provides comprehensive clinical laboratory services, including tests for maternal and fetal health, directly competing with Sera Prognostics.
Myriad Genetics
MYGN
Mkt Cap550.63M
Myriad Genetics offers genetic testing and precision medicine, including prenatal tests, competing in the same space as Sera Prognostics.
Fulgent Genetics
FLGT
Mkt Cap583.63M
Fulgent Genetics offers genetic testing for various conditions, including reproductive health, making it a competitor in the prenatal testing market.
Thermo Fisher Scientific
TMO
Mkt Cap195.86B
Thermo Fisher Scientific provides a wide range of scientific research and diagnostic tools, including those used in prenatal testing, making them a competitor in the broader diagnostics market.
Bio-Rad Laboratories
BIO
Mkt Cap7.92B
Bio-Rad Laboratories offers products and services for life science research and clinical diagnostics, including prenatal testing, competing in the diagnostics and research market.
Guardant Health
GH
Mkt Cap21.22B
Guardant Health focuses on cancer diagnostics but its advanced genomic sequencing capabilities make it a potential competitor in the broader market for genetic testing, including prenatal diagnostics.

About

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Show more...
CEO
Ms. Zhenya Lindgardt M.B.A.
Employees
63
Country
United States
ISIN
US81749D1072

Listings

XNAS
US
SERA
BOATS
BOATS
SERA.BOATS

0 Comments

Share your thoughts

FAQ

What is Sera Prognostics stock price today?▼
The current price of SERA is $2.05 USD — it has decreased by -6.82% in the past 24 hours. Watch Sera Prognostics stock price performance more closely on the chart.
What is Sera Prognostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sera Prognostics stocks are traded under the ticker SERA.
Is Sera Prognostics stock price growing?▼
SERA stock has risen by +4.06% compared to the previous week, the month change is a +17.14% rise, over the last year Sera Prognostics has showed a -29.79% decrease.
What is Sera Prognostics market cap?▼
Today Sera Prognostics has the market capitalization of 80.28M
When is the next Sera Prognostics earnings date?▼
Sera Prognostics is going to release the next earnings report on August 12, 2026.
What were Sera Prognostics earnings last quarter?▼
SERA earnings for the last quarter are -0.17 USD per share, whereas the estimation was -0.17 USD resulting in a -2% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sera Prognostics revenue for the last year?▼
Sera Prognostics revenue for the last year amounts to 81,000 USD.
What is Sera Prognostics net income for the last year?▼
SERA net income for the last year is -31.93M USD.
How many employees does Sera Prognostics have?▼
As of July 18, 2026, the company has 63 employees.
In which sector is Sera Prognostics located?▼
Sera Prognostics operates in the Health & Wellness sector.
When did Sera Prognostics complete a stock split?▼
Sera Prognostics has not had any recent stock splits.
Where is Sera Prognostics headquartered?▼
Sera Prognostics is headquartered in Salt Lake City, United States.